http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100984213-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D307-93 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-365 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D307-93 |
| filingDate | 2003-02-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2010-09-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2010-09-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-100984213-B1 |
| titleOfInvention | Novel Farnesyl Transferase Inhibitors |
| abstract | The present invention relates to a novel hydrocarbon ring lactone derivative compound represented by the following formula (I), (II) or (III) having farnesyl transferase inhibitory action. The present invention also provides a method for preparing the compound, the therapeutic effect of a disease containing the compound or a pharmaceutically acceptable salt thereof as an active ingredient and mediated through farnesylation, in particular anti-cancer, anti-proliferation, anti-inflammatory, immunosuppression, It relates to a pharmaceutical composition having an autoimmune disease treatment and muscle relaxation effect:n n n n n n n n Farnesyl Transferase Inhibitors, Hydrocarbon Cyclolactones, and Aglavine Derivatives |
| priorityDate | 2003-02-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 132.